Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

News > All

Total search results: 9863 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 12 13 14 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Carrick Therapeutics Ltd.. (11/30/17). "Press Release: Carrick Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of iIts Oral CDK7 inhibitor – CT7001". 2017-11-30
Akouos. (11/30/17). "Press Release: Akouos to Build Premier Gene Therapy Company Focused on Hearing and Balance Disorders with Backing from Leading Life Science Investors and Strategic Licenses from Massachusetts Eye and Ear and Lonza". Boston, MA & Hous 2017-11-30
Sanofi S.A.. (11/29/17). "Press Release: Sanofi Updates Information on Dengue Vaccine. New Analysis of Long-term Dengvaxia Data Found Differences in Vaccine Performance Based on Prior Dengue Infection". Paris. 2017-11-29
Epigenomics AG. (11/29/17). "Press Release: Supervisory Board of Epigenomics AG Appoints Albert Weber as Executive Vice President Finance and a Member of the Management Board (Vorstand)". Berlin & Germantown, MD. 2017-11-29
Bluebird Bio, Inc.. (11/29/17). "Press Release: Bluebird Bio Acquires Manufacturing Facility in North Carolina and Executes Multiple Global Supply Agreements to Enhance Ability to Deliver Gene Therapies to Patients". Cambridge, MA. 2017-11-29
Siemens AG. (11/29/17). "Press Release: Siemens Plans to List Siemens Healthineers on Frankfurt Stock Exchange". Munich. 2017-11-29
Cullinan Oncology, LLC. (11/29/17). "Press Release: Cullinan Oncology Adds Industry Leaders to Board, Bringing Significant Business & Healthcare Acumen". Cambridge, MA. 2017-11-29
Genedata AG. (11/28/17). "Press Release: New Release of Genedata Selector Revolutionizes Genomic Data Management and Analysis for Key Biopharma Applications". Basel. 2017-11-28
iOnctura S.A.. (11/28/17). "Press Release: iOnctura Announces Appointment of Leading International Scientific Advisory Board". Geneva. 2017-11-28
Charles River Laboratories International, Inc.. (11/28/17). "Press Release: Charles River Announces Success of Integrated Discovery Project with Enyo Pharma". Wilmington, MA & Lyon. 2017-11-28
Sphere Fluidics Ltd.. (11/27/17). "Press Release: Sphere Fluidics and Geneva Biotech Receive Eurostars Genome Editing Grant". Cambridge & Geneva. 2017-11-27
Medigene AG. (11/27/17). "Press Release: Patient Recruitment Completed for Phase I/II DC Vaccine Trial in AML". Planegg. 2017-11-27
BioMed X GmbH. (11/27/17). "Press Release: BioMed X and Boehringer Ingelheim Start New Joint Research Group in Bacterial Modulation of Innate Immunity". Heidelberg. 2017-11-27
Analytik Jena AG. (11/27/17). "Press Release: Analytik Jena and BAM Agree to Cooperate in Research". Jena. 2017-11-27
Bayer AG. (11/27/17). "Press Release: Bayer Is Expanding Its Collaboration with Bitkom". Leverkusen & Berlin. 2017-11-27
Biocartis Group N.V.. (11/27/17). "Press Release: Biocartis Launches CE-marked IVD RAS Liquid Biopsy Tests Developed under Partnership with Merck KGaA, Darmstadt, Germany". Mechelen. 2017-11-27
MorphoSys AG. (11/23/17). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Received Approval for Tremfya (Guselkumab) in Europe for the Treatment of Moderate-to-Severe Plaque Psoriasis". Planegg. 2017-11-23
Royal Philips. (11/23/17). "Press Release: Philips-led Research Consortium Awarded EUR 6.3 Million EU Grant to Develop Integrated Approaches for Personalized Cancer Treatment". Amsterdam. 2017-11-23
Abivax S.A.. (11/20/17). "Press Release: Abivax Enrolls First Ulcerative Colitis Patient in New ABX464 Proof-of-Concept Clinical Trial". Paris. 2017-11-20
Boehringer Ingelheim. (11/20/17). "Press Release: Boehringer Ingelheim Makes Many of Its Best Molecules Openly Available to the Scientific Community via opnMe.com to Unlock Their Full Potential". Ingelheim. 2017-11-20
Jennewein Biotechnologie GmbH. (11/20/17). "Press Release: EU Approval for 2'-fucosyllactose". 2017-11-20
Arsanis, Inc.. (11/20/17). "Press Release: Arsanis Announces Closing of Initial Public Offering". Waltham, MA & Vienna. 2017-11-20
Roche. (11/17/17). "Press Release: FDA Approves Roche’s Gazyva for Previously Untreated Advanced Follicular Lymphoma". Basel. 2017-11-17
Roche. (11/17/17). "Press Release: Roche to Acquire Viewics, Inc. to Provide Data-driven Lab Business Analytics and Add further Digital Capabilities along the Laboratory Value Chain". Basel. 2017-11-17
Ncardia. (11/17/17). "Press Release: Ncardia Announces Completion of €10.5m Investment Round". Gosselies. 2017-11-17
Formycon AG. (11/16/17). "Press Release: Formycon Sets Course for the Future and Confirms Management Board Members until mid-2022". Munich. 2017-11-16
Goodwin Procter LLC. (11/16/17). "Press Release: Intellia Therapeutics Closes $150 Million Public Offering of Common Stock". 2017-11-16
High-Tech Gründerfonds Management GmbH. (11/16/17). "Press Release: EWE Invests in High-Tech Gründerfonds III". 2017-11-16
Molecular Health GmbH. (11/16/17). "Press Release: Molecular Health and U.S. Food and Drug Administration (FDA) Extend Software Collaboration to Drug Safety Prediction". Cambridge, MA. 2017-11-16
Ablynx N.V.. (11/16/17). "Press Release: Ablynx Announces Results for the First Nine Months of 2017 and a Year-to-Date Business Update". Ghent. 2017-11-16
Biocartis Group N.V.. (11/16/17). "Press Release: Biocartis Q3 2017 Business Update". Mechelen. 2017-11-16
bio.logis Genetic Information Management GmbH. (11/16/17). "Press Release: Laboratory Group Laboratoires Réunis Capitalizes Genetic Information Management Software Suite for Complex Laboratory Reports". 2017-11-16
Curetis N.V.. (11/16/17). "Press Release: Curetis Publishes Business and Financial Update for the First Nine Months of 2017". Amsterdam & Holzgerlingen. 2017-11-16
Roche. (11/16/17). "Press Release: FDA Approves Roche’s Hemlibra (emicizumab-kxwh) for Haemophilia A with Inhibitors". Basel. 2017-11-16
Boehringer Ingelheim. (11/15/17). "Press Release: Key Sub-analyses of RE-DUAL PCI Showed Large Reductions in the Incidence of Bleeding Complications if Pradaxa (dabigatran etexilate) Dual Therapy Was Used Instead of Warfarin Triple Therapy". Ingelheim. 2017-11-15
Arvinas, LLC. (11/15/17). "Press Release: Arvinas Expands Strategic License Agreement with Genentech". New Haven, CT. 2017-11-15
Xeltis AG. (11/15/17). "Press Release: Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs". Zurich & Eindhoven. 2017-11-15
Arsanis, Inc.. (11/15/17). "Press Release: Arsanis Announces Pricing of Initial Public Offering". Waltham, MA & Vienna. 2017-11-15
High-Tech Gründerfonds Management GmbH. (11/14/17). "Press Release: Scipio Bioscience Announces Its Seed Funding". 2017-11-14
Boehringer Ingelheim. (11/14/17). "Press Release: Jardiance Reduced Risk of Cardiovascular Death in Adults with Type 2 Diabetes and Peripheral Artery Disease". Ingelheim & Indianapolis, IN. 2017-11-14
Boehringer Ingelheim. (11/14/17). "Press Release: New RE-VERSE AD Analyses Provide Additional Insights on Impact of Praxbind (idarucizumab) in Pradaxa (dabigatran etexilate) Patients with Gastrointestinal Bleeding or Needing Emergency Surgery". Ingelheim 2017-11-14
Loxo Oncology, Inc.. (11/14/17). "Press Release: Loxo Oncology Announces Global Development and Commercialization Partnership with Bayer for Larotrectinib and LOXO-195". Stamford, CT. 2017-11-14
Qiagen N.V.. (11/14/17). "Press Release: Qiagen’s GeneReader NGS System Delivers Accuracy and Ease of Use for Clinical Research in Oncology". Hilden & Germantown, MD. 2017-11-14
Definiens AG. (11/13/17). "Press Release: Definiens Strengthens Position as Global Service Provider in Biopharma. Jacques Corriveau Joining as General Manager North America". Munich. 2017-11-13
CRISPR Therapeutics AG. (11/13/17). "Press Release: CRISPR Therapeutics and Casebia Collaborate with CureVac on mRNA for Gene-Editing Programs". Zug, Cambridge, MA, Tübingen & Boston, MA. 2017-11-13
Boehringer Ingelheim. (11/13/17). "Press Release: Cyltezo, Adalimumab Biosimilar from Boehringer Ingelheim, Approved in Europe for the Treatment of Multiple Chronic Inflammatory Diseases". Ingelheim. 2017-11-13
CRISPR Therapeutics AG. (11/13/17). "Press Release: CRISPR Therapeutics Announces Appointment of Michael Tomsicek as Chief Financial Officer". Zug & Cambridge, MA. 2017-11-13
Merck KGaA. (11/13/17). "Press Release: Merck and International Diabetes Federation Partner to Help Address Global Type 2 Diabetes Epidemic [The information contained in this release is not appropriate for audiences in the USA and Canada]". Darmstadt. 2017-11-13
Merck KGaA. (11/13/17). "Press Release: Merck Introduces Stericup Quick Release System for Improved Cell Culture Filtration". Darmstadt. 2017-11-13
Merck KGaA. (11/13/17). "Press Release: Merck Receives FDA Approval for New Gonal-f Prefilled Pen [Not intended for U.S. and UK based media]". Darmstadt. 2017-11-13
Royal Philips. (11/13/17). "Press Release: German Armed Forces to Use Customized Philips Lumify Ultrasound for Its Emergency and Rescue Operations". Amsterdam. 2017-11-13
Qiagen N.V.. (11/13/17). "Press Release: Qiagen Celebrates Surpassing 2,000 Cumulative Placements of QIAsymphony". Hilden & Germantown, MD. 2017-11-13
EBD Group. (11/13/17). "Press Release: BIO-Europe 2017 Brings over 4,000 Biotech and Pharma Execs to Berlin and Breaks All Previous Partnering Records". Carlsbad, CA & Berlin. 2017-11-13
GNA Biosolutions GmbH. (11/13/17). "Press Release: GNA Biosolutions Reveals New Ultrafast PCR Platform at Medica". Düsseldorf. 2017-11-13
Affimed N.V.. (12/11/17). "Press Release: Affimed Presents Data from Phase 1b Combination Study of AFM13 with Pembrolizumab at ASH". Heidelberg. 2017-11-12
Boehringer Ingelheim. (11/10/17). "Press Release: Boehringer Ingelheim Presents New Data for Pradaxa and Its Specific Reversal Agent Praxbind at AHA Scientific Sessions 2017". Ingelheim. 2017-11-10
DiaSorin S.p.A.. (11/9/17). "Press Release: Growth in Revenues and Net Profit in Q3 2017". Saluggia. 2017-11-09
Vetter Pharma International GmbH. (11/9/17). "Press Release: Vetter Expands Its Footprint in Asia Pacific Region. Company Establishes Its Presence in South Korea". Songdo & Ravensburg. 2017-11-09
Valneva S.E.. (11/9/17). "Press Release: Valneva Reports Strong Operational Performance for the First Nine Months of 2017". Lyon. 2017-11-09
Neurimmune AG. (11/9/17). "Press Release: Neurimmune Announces Collaboration with Ono Pharmaceutical in Neurodegenerative Diseases Field". Schlieren. 2017-11-09
InflaRx N.V.. (11/8/17). "Press Release: InflaRx Announces Pricing of Initial Public Offering". Jena. 2017-11-08
Boehringer Ingelheim. (11/8/17). "Press Release: Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases". Ingelheim & London. 2017-11-08
Definiens AG. (11/8/17). "Press Release: Definiens Broadens Immuno-Oncology Service Offer. Predictive Multi-biomarkers for Accelerated Immuno-oncological Progress". Washington, D.C.. 2017-11-08
Evotec AG. (11/8/17). "Press Release: Evotec AG Announces First Nine-month 2017 Results and Corporate Update". Hamburg. 2017-11-08
CRISPR Therapeutics AG. (11/8/17). "Press Release: CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business Update". Zug & Cambridge, MA. 2017-11-08
Endress+Hauser AG. (11/8/17). "Press Release: Endress+Hauser Acquires Blue Ocean Nova. Intelligent Inline Spectrometers Strengthen the Process Analytical Instrumentation Portfolio". 2017-11-08
G1 Therapeutics, Inc.. (11/8/17). "Press Release: G1 Therapeutics Makes Key Executive Appointments. Barclay Phillips Appointed Chief Financial Officer and Senior Vice President, Corporate Development". Research Triangle Park, NC. 2017-11-08
MorphoSys AG. (11/7/17). "Press Release: MorphoSys Announces Third Quarter 2017 Results". Planegg. 2017-11-07
Compugen Ltd.. (11/7/17). "Press Release: Compugen Reports Third Quarter 2017 Results". Holon. 2017-11-07
Valneva S.E.. (11/7/17). "Press Release: Valneva Signs $39.6 Million Ixiaro Supply Contract with US Government". Lyon. 2017-11-07
NousCom AG. (11/6/17). "Press Release: NousCom Raises €42 Million Series B Financing". Basel. 2017-11-06
Boehringer Ingelheim. (11/6/17). "Press Release: Efficacy and Safety Maintained in Patients Who Switched from Humira to Biosimilar Cyltezo". Ingelheim. 2017-11-06
Compugen Ltd.. (11/6/17). "Press Release: Compugen to Initiate Manufacturing of COM902, Its Lead antiTIGIT Monoclonal Antibody". Holon. 2017-11-06
Eurofins Scientific. (11/6/17). "Press Release: Eurofins Successfully Prices EUR 400m New Hybrid Bond". 2017-11-06
Evotec AG. (11/6/17). "Press Release: Evotec Joins Forces with Academic Leaders to Accelerate Drug Discovery in Kidney Diseases and Build »NEPLEX«". Hamburg. 2017-11-06
Qiagen N.V.. (11/6/17). "Press Release: Qiagen Reports Results for Third Quarter and First Nine Months of 2017". Venlo. 2017-11-06
Glycotope GmbH. (11/3/17). "Press Release: Celonic Acquires Glycotope’s Biomanufacturing Facility". Basel. 2017-11-03
Boehringer Ingelheim. (11/2/17). "Press Release: Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Novel Treatments for Chronic Liver Diseases including Nonalcoholic Steatohepatitis (NASH)". Ingelheim & Cambridge, MA. 2017-11-02
Topas Therapeutics GmbH. (11/2/17). "Press Release: Topas Therapeutics Extends Its Series A to EUR 18 Million (USD 21 Million) with Boehringer Ingelheim Venture Fund". Hamburg. 2017-11-02
Bruker Corporation. (11/2/17). "Press Release: Bruker Reports Third Quarter 2017 Financial Results". Billerica, MA. 2017-11-02
Servier. (11/2/17). "Press Release: Servier Germany to Co-promote Novartis’ Blockbuster Entresto". 2017-11-02
Merck KGaA. (11/1/17). "Press Release: Merck and Samsung BioLogics to Extend Strategic Alliance". Darmstadt. 2017-11-01
Bruker Corporation. (11/1/17). "Press Release: Bruker Merger of Sweden Subsidiaries". Solna. 2017-11-01
Novartis AG. (10/30/17). "Press Release: Novartis to Present First of its Kind Evidence for Cosentyx on Potential to Maintain Mobility in Patients with AS and PsA". Basel. 2017-10-30
Novartis AG. (10/30/17). "Press Release: Novartis Announces the Planned Acquisition of Advanced Accelerator Applications to Strengthen Oncology Portfolio". Basel. 2017-10-30
CureVac AG. (10/30/17). "Press Release: CureVac Announces Groundbreaking of Industrial-Scale GMP Production Facility for RNA Therapeutics". Tübingen. 2017-10-30
MorphoSys AG. (10/30/17). "Press Release: Dr. Markus Enzelberger Appointed MorphoSys's Chief Scientific Officer". Planegg. 2017-10-30
Euronext N.V.. (10/30/17). "Press Release: Theranexus Takes Its First Steps on Euronext Growth". Paris. 2017-10-30
Boehringer Ingelheim. (10/30/17). "Press Release: Boehringer Ingelheim Expands Collaboration with Sarah Cannon Research Institute to Investigate Novel Immuno-oncology Combination Therapy". Ingelheim & Nashville, TN. 2017-10-30
Glycotope GmbH. (10/30/17). "Press Release: Daiichi Sankyo and Glycotope Announce Option Agreement for Antibody Drug Conjugate Strategic Collaboration and Licensing". Tokyo, Basking Ridge, NJ & Berlin. 2017-10-30
Kymera Therapeutics LLC. (10/30/17). "Press Release: Kymera Therapeutics Announces Series A to Advance Novel Therapeutic Modality and Develop Innovative Therapies". Cambridge, MA. 2017-10-30
Qiagen N.V.. (10/30/17). "Press Release: Qiagen Accelerates Adoption of Molecular Testing for Life Sciences and Molecular Diagnostics Companies with Launch of Custom Solutions Business". Beverly, MA. 2017-10-30
Novartis AG. (10/28/17). "Press Release: Novartis PARADIGMS Data Show Children and Adolescents with MS Had an 82% Lower Relapse Rate with Gilenya vs. Interferon beta-1a". Basel. 2017-10-28
Novartis AG. (10/27/17). "Press Release: Sandoz Proposed Biosimilar Pegfilgrastim Accepted by EMA for Regulatory Review". Holzkirchen. 2017-10-27
Clariant. (10/27/17). "Press Release: Clariant and Huntsman Jointly Decided to Abandon Planned Merger of Equals". Muttenz. 2017-10-27
CureVac AG. (10/27/17). "Press Release: CureVac Initiates Phase I Clinical Trial of RNAdjuvant Candidate as Intratumoral Therapy for Solid Tumors". Tübingen & Boston, MA. 2017-10-27
4SC AG. (10/26/17). "Press Release: 4SC Provides Q3 and 9M 2017 Update". Planegg-Martinsried. 2017-10-26
Topas Therapeutics GmbH. (10/26/17). "Press Release: Topas Therapeutics Appoints Rupert Sandbrink, M.D., Ph.D., as Chief Development Officer and Chief Medical Officer". Hamburg. 2017-10-26
Akampion. (10/26/17). "Press Release: Akampion Hosts Expert Panel at BIO-Europe 2017, Co-authors Scientific Article in Human Gene Therapy". 2017-10-26
Evolva Holding S.A.. (10/26/17). "Press Release: Evolva Announces Final Terms of Proposed Capital Increase [Not for release in US, CA, JP or AU or any jurisdiction where unlawful]". 2017-10-26
next pagenext page 1 2 3 ... 12 13 14 ... 97 98 99  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top